Debora Barton, M.D.

Debora Barton, M.D.

Former Chief Medical OfficeratTScan Therapeutics· In the 2023 proxy

Pay in FY2023TScan Therapeutics stock +276.1% the same year

Debora Barton, M.D. was paid $1.7M in FY2023 (Dec). TScan Therapeutics stock rose 276.1% that year.

Pay$100 in the stock at the end of FY22 → $376
Pay is from the Summary Compensation Table of each TScan Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TScan TherapeuticsPublic company · 3 yr
    • Former Chief Medical Officer2023 – Present · 3 yrStock in role -87%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?